Results 101 to 110 of about 489 (164)

[Real-world evidence on the use of generic tofacitinib in patients with rheumatoid arthritis] [PDF]

Rev Fac Cien Med Univ Nac Cordoba
Di Giuseppe LA, Burgos MA, Posadas Martínez ML, Vargas Casalles AL, Alvarez KE, Buela G, Puga MC, Soriano Guppy ER, Rosa JE.   +8 more
europepmc   +1 more source

[Methadone as a rescue drug for difficult-to-sedate critically ill patients suffering from ARDS related to SARS-CoV-2 infection]. [PDF]

Med Intensiva, 2022
Fernández-Tobar R, Chamorro-Jambrina C, Pérez-Torres M, Castiñeiras-Amor B, Alcántara-Carmona S, Romera-Ortega MA.   +5 more
europepmc   +1 more source

[Inhaled levodopa: from evidence to experience]. [PDF]

Rev Neurol
Martínez-Castrillo JC, Pareés-Moreno I, López Sendón-Moreno JL, Pérez-Torre P, Fanjul S, Patiño-Patón A, García-Ribas G, Alonso-Cánovas A.   +7 more
europepmc   +1 more source

[Ziresovir: a potent, selective, and oral inhibitor of the respiratory syncytial virus fusion (F) protein]. [PDF]

Rev Esp Quimioter
Reina J, Bosch-Durán J.
europepmc   +1 more source

[Association between single nucleotide genetic polymorphisms in ABC transporter genes with drug-resistant epilepsy in the Spanish population]. [PDF]

Rev Neurol, 2022
Nava-Cedeño DJ, Alonso-Cerezo MC, Sanz-García A, Vega-Zelaya L, Gordillo-Perdomo JJ, Toledo-Heras M, Pastor-Gómez J, Torres-Díaz C, Pulido-Rivas P, García-Sola R.   +9 more
europepmc   +1 more source

Incidencia y transiciones de presión arterial en trabajadores: análisis longitudinal. [PDF]

Arch Cardiol Mex
Vera-Ponce VJ, Zuzunaga-Montoya FE, Valladolid-Sandoval LAM, Bustamante-Rodríguez JC, Vásquez-Romero LEM, Loayza-Castro JA, Gutierrez-De Carrillo CI, Montoya-Goicochea DC.   +7 more
europepmc   +1 more source

Application of Accelerated Predictive Stability Studies in Extemporaneously Compounded Formulations of Chlorhexidine to Assess the Shelf Life. [PDF]

Molecules, 2023
González-González O, Ballesteros MP, Torrado JJ, Serrano DR.   +3 more
europepmc   +1 more source

[Monoclonal Antibodies in Allergic Diseases: Development, Pharmacology, and Clinical Applications] [PDF]

Rev Fac Cien Med Univ Nac Cordoba
Pury S, Saranz RJ, Irastorza MJ, Sasia LV, Visconti P, Alegre G, Lozano NA, Berardi YV, Lozano A.   +8 more
europepmc   +1 more source

[Safety in the selection of oral antibiotic treatment in community infections, beyond COVID-19]. [PDF]

Rev Esp Quimioter, 2021
Barberán J, Barberán LC, de la Cuerda A.   +2 more
europepmc   +1 more source

[Drug Excipients. Necessary, but not Harmless]. [PDF]

Farm Comunitarios
López Alarcón MD, Justo Hernández A, Santos Cruz P.   +2 more
europepmc   +1 more source